TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8140
-0.0761 (-8.55%)
At close: May 26, 2026, 4:00 PM EDT
0.8384
+0.0244 (3.00%)
After-hours: May 26, 2026, 7:55 PM EDT

TELA Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-39.84-38.83-37.84-46.66-44.3-33.28
Depreciation & Amortization
1.011.011.010.811.190.54
Stock-Based Compensation
3.573.84.365.033.993.66
Other Adjustments
3.894.39-4.291.644.142.12
Change in Receivables
0.89-0.11-0.76-3.06-2.42-1.55
Changes in Inventories
-1.32-0.5-2.97-2.72-6.07-5.19
Changes in Accounts Payable
-0.120.140.480.01-0.881.4
Changes in Accrued Expenses
1.191.76-1.814.182.42.67
Changes in Other Operating Activities
0.180.130.23-0.081.22-0.99
Operating Cash Flow
-29.66-28.22-41.6-40.86-40.75-30.43
Capital Expenditures
-0.54-0.45-0.99-0.61-0.87-0.63
Sale of Property, Plant & Equipment
---0.01--
Purchases of Intangible Assets
-----1-
Proceeds from Business Divestments
1.431.295.44---
Investing Cash Flow
0.90.854.45-0.6-1.87-0.63
Long-Term Debt Issued
-60--40-
Long-Term Debt Repaid
--42.42---30-
Net Long-Term Debt Issued (Repaid)
-17.58--10-
Issuance of Common Stock
0.0711.9343.4346.5634.470.59
Repurchase of Common Stock
-0.11-0.21-0.37-0.29-0.16-
Net Common Stock Issued (Repurchased)
-0.0311.7243.0646.2734.310.59
Other Financing Activities
-0.25-3.55---3.46-
Financing Cash Flow
25.5725.7543.0646.2740.850.59
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.11-0.220.030.16-0.140.01
Net Cash Flow
-3.31-1.845.944.98-1.91-30.46
Free Cash Flow
-30.2-28.67-42.58-41.47-41.62-31.06
FCF Margin
-37.37%-35.71%-61.45%-70.94%-100.49%-105.42%
Free Cash Flow Per Share
-0.60-0.61-1.49-1.81-2.56-2.15
Levered Free Cash Flow
-39.43-19.16-41.89-45.08-37.32-35.48
Unlevered Free Cash Flow
-33.6-31.86-38.03-42.49-42.03-31.66
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q